BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1521155)

  • 1. Limited and selective adduction of carboxyl-terminal lysines in the high molecular weight neurofilament proteins by 2,5-hexanedione in vitro.
    DeCaprio AP; Fowke JH
    Brain Res; 1992 Jul; 586(2):219-28. PubMed ID: 1521155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regioselective binding of 2,5-hexanedione to high-molecular-weight rat neurofilament proteins in vitro.
    DeCaprio AP; Kinney EA; Fowke JH
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):211-7. PubMed ID: 9221839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative covalent protein binding of 2,5-hexanedione and 3-acetyl-2,5-hexanedione in the rat.
    DeCaprio AP; Kinney EA; LoPachin RM
    J Toxicol Environ Health A; 2009; 72(14):861-9. PubMed ID: 19557614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure.
    DeCaprio AP; O'Neill EA
    Toxicol Appl Pharmacol; 1985 Apr; 78(2):235-47. PubMed ID: 3929425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gamma-diketone peripheral neuropathy. II. Neurofilament subunit content.
    Chiu FC; Opanashuk LA; He DK; Lehning EJ; LoPachin RM
    Toxicol Appl Pharmacol; 2000 Jun; 165(2):141-7. PubMed ID: 10828209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 2,5-hexanedione on calpain-mediated degradation of human neurofilaments in vitro.
    Heijink E; Scholten SW; Bolhuis PA; de Wolff FA
    Chem Biol Interact; 2000 Dec; 129(3):231-47. PubMed ID: 11137063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,5-Hexanedione-induced changes in the monomeric neurofilament protein content of rat spinal cord fractions.
    LoPachin RM; He D; Reid ML; Opanashuk LA
    Toxicol Appl Pharmacol; 2004 Jul; 198(1):61-73. PubMed ID: 15207649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamic study of neurofilament contents in rat's spinal cord induced by 2, 5-hexanedione].
    Song FY; Wang QS; Zeng T; Yu LH; Zhu ZP; Xie KQ
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Oct; 26(10):588-91. PubMed ID: 19272251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pyrrole formation in the alteration of neurofilament transport induced during exposure to 2,5-hexanedione.
    Pyle SJ; Amarnath V; Graham DG; Anthony DC
    J Neuropathol Exp Neurol; 1992 Jul; 51(4):451-8. PubMed ID: 1619444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro binding of [14C]2,5-hexanedione to rat neuronal cytoskeletal proteins.
    Lanning CL; Wilmarth KR; Abou-Donia MB
    Neurochem Res; 1994 Sep; 19(9):1165-73. PubMed ID: 7824070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat.
    DeCaprio AP; Briggs RG; Jackowski SJ; Kim JC
    Toxicol Appl Pharmacol; 1988 Jan; 92(1):75-85. PubMed ID: 3341029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of cytoskeletal proteins in nerve tissues and serum of rats treated with 2,5-hexanedione.
    Wang QS; Hou LY; Zhang CL; Song FY; Xie KQ
    Toxicology; 2008 Feb; 244(2-3):166-78. PubMed ID: 18177991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport.
    Monaco S; Wongmongkolrit T; Shearson CM; Patton A; Schaetzle B; Autilio-Gambetti L; Gambetti P; Sayre LM
    Brain Res; 1990 Jun; 519(1-2):73-81. PubMed ID: 2118823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decelerated transport and its mechanism of 2,5-hexanedione on middle-molecular-weight neurofilament in rat dorsal root ganglia cells.
    Han XY; Cheng D; Song FY; Zeng T; An LH; Xie KQ
    Neuroscience; 2014 Jun; 269():192-8. PubMed ID: 24699225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,5-hexanedione altered the degradation of low-molecular-weight neurofilament in rat nerve tissues.
    Song F; Zhang Q; Kou R; Zou C; Gao Y; Xie K
    Food Chem Toxicol; 2012 Dec; 50(12):4277-84. PubMed ID: 22967723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of neurofilament H subunit at the tail domain by CDC2 kinase dissociates the association to microtubules.
    Hisanaga S; Kusubata M; Okumura E; Kishimoto T
    J Biol Chem; 1991 Nov; 266(32):21798-803. PubMed ID: 1939202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-state 13C-NMR spectroscopy of adduction products of 2,5-hexanedione with ribonuclease, albumin, and rat neurofilament protein.
    Yan B; DeCaprio AP; Zhu M; Bank S
    Chem Biol Interact; 1996 Oct; 102(2):101-16. PubMed ID: 8950225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal transport of neurofilament is accelerated in peripheral nerve during 2,5-hexanedione intoxication.
    Monaco S; Jacob J; Jenich H; Patton A; Autilio-Gambetti L; Gambetti P
    Brain Res; 1989 Jul; 491(2):328-34. PubMed ID: 2475210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II.
    Miyasaka H; Okabe S; Ishiguro K; Uchida T; Hirokawa N
    J Biol Chem; 1993 Oct; 268(30):22695-702. PubMed ID: 8226779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxyl-terminus of Hsc70 interacting protein mediates 2,5-hexanedione-induced neurofilament medium chain degradation.
    Wang Q; Song F; Zhang C; Zhao X; Zhu Z; Yu S; Xie K
    Biochem Pharmacol; 2011 Mar; 81(6):793-9. PubMed ID: 21219885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.